BioDue SpA logo

BIO2 - BioDue SpA Share Price

€6.48 0.0  0.0%

Last Trade - 06/12/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £36.1m
Position in Universe th / 730
Bullish
Bearish
Unlock BIO2 Revenue
Momentum
Relative Strength (%)
1m -1.96%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
26.9 30.0 33.6 34.3 35.7 41.0 44.4 48.6 +8.8%
-22.2 +57.8 -58.7 -7.1 +83.9 -1.8 +20.4 +25.6
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2019, Biodue SpArevenues increased 3% to EUR21.6M. Net income decreased 7%to EUR1.6M. Revenues reflect Italy segment increase of 6%to EUR19M. Net income was offset by Other Service Costsincrease of 15% to EUR4.5M (expense), Depreciation increaseof 22% to EUR982K (expense). Basic Earnings per Shareexcluding Extraordinary Items decreased from EUR0.16 toEUR0.15.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BIO2 Revenue Unlock BIO2 Revenue

Net Income

BIO2 Net Income Unlock BIO2 Revenue

Normalised EPS

BIO2 Normalised EPS Unlock BIO2 Revenue

PE Ratio Range

BIO2 PE Ratio Range Unlock BIO2 Revenue

Dividend Yield Range

BIO2 Dividend Yield Range Unlock BIO2 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BIO2 EPS Forecasts Unlock BIO2 Revenue
Profile Summary

BioDue SpA is an Italy-based consolidated industrial and commercial enterprise oriented towards the research, development, production and commercialization of cosmetic products, medical devices and food supplements, both liquid and solid. It manages almost its entire supply chain from raw materials to the research and development of formulations, right up to the production and relative commercialization of products throughout the world. The Company is structured around two divisions with specific competencies: Contract Manufacturing and Brand Owner. Contract Manufacturing is entirely dedicated to the manufacture of third party brand solid and liquid food supplements, cosmetics and medical devices. Brand Owner manufactures and commercializes own-brand dermatological, ophthalmic products and food supplements under the brands Pharcos, Biofta, Selerbe.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Public Since May 20, 2015
No. of Shareholders: n/a
No. of Employees: 169
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Borsa Italiana
Shares in Issue 11,087,900
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BIO2 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BIO2
Upcoming Events for BIO2
Frequently Asked Questions for BioDue SpA
What is the BioDue SpA share price?

As of 06/12/19, shares in BioDue SpA are trading at €6.48, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the BioDue SpA share price performed this year?

Shares in BioDue SpA are currently trading at €6.48 and the price has moved by 24.62% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the BioDue SpA price has moved by 15.11% over the past year.

What are the analyst and broker recommendations for BioDue SpA?

Of the analysts with advisory recommendations for BioDue SpA, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for BioDue SpA is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will BioDue SpA next release its financial results?

BioDue SpA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-06-30
What is the BioDue SpA dividend yield?

The BioDue SpA dividend yield is % based on the trailing twelve month period.

Does BioDue SpA pay a dividend?

Last year, BioDue SpA paid a total dividend of 0.1, and it currently has a trailing dividend yield of %. Looking ahead, BioDue SpA has not announced an ex-dividend date yet.

When does BioDue SpA next pay dividends?

BioDue SpA has yet to annouce their ex-dividend date. The historic dividend yield on BioDue SpA shares is currently %.

How do I buy BioDue SpA shares?

To buy shares in BioDue SpA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of BioDue SpA?

Shares in BioDue SpA are currently trading at €6.48, giving the company a market capitalisation of £n/a.

Where are BioDue SpA shares listed? Where are BioDue SpA shares listed?

Here are the trading details for BioDue SpA:

Country of listing: Italy
Exchange: MIL
Ticker Symbol: BIO2
What kind of share is BioDue SpA?

We were not able to load our ranking data for BioDue SpA

Is there a BioDue SpA share price forecast 2021?

We were not able to load any forecast data for BioDue SpA.

How can I tell whether the BioDue SpA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioDue SpA. Over the past six months, the relative strength of its shares against the market has been 9.47%. At the current price of €6.48, shares in BioDue SpA are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the BioDue SpA PE Ratio?

We were not able to find PE ratio data for BioDue SpA.

Who are the key directors of BioDue SpA?

We were unable to find the directors for BioDue SpA.

Who are the major shareholders of BioDue SpA?

Here are the top five shareholders of BioDue SpA based on the size of their shareholding:

Similar to BIO2
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.